Literature DB >> 2989436

Peripheral neuropathy during longterm high-dose amiodarone therapy.

A G Fraser, I N McQueen, A H Watt, M R Stephens.   

Abstract

Three patients developed peripheral neuropathy after taking amiodarone for more than 18 months. All had high serum concentrations of amiodarone and its desethyl metabolite; in one patient concentrations in a sural nerve biopsy were 80 times higher than in serum. Peripheral neuropathy is a complication of large doses of amiodarone taken over long periods.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2989436      PMCID： PMC1028375          DOI： 10.1136/jnnp.48.6.576

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  15 in total

1.  Amiodarone neuropathy (author's transl).

Authors:  H E Kaeser; J Ulrich; R Wüthrich
Journal:  Schweiz Rundsch Med Prax       Date:  1976-09-14

2.  [2 cases of peripheral neuropathy caused by amiodarone].

Authors:  C Fischer; B Bady; M Trillet; B Schott
Journal:  Nouv Presse Med       Date:  1977-11-19

3.  Letter: Amiodarone and neurological side-effects.

Authors:  F Lustman; G Monseu
Journal:  Lancet       Date:  1974-03-30       Impact factor: 79.321

4.  [Amiodarone neuropathy].

Authors:  H E Kaeser
Journal:  Schweiz Med Wochenschr       Date:  1974-04-27

5.  [Neuropathy induced by amiodarone].

Authors:  P Larre; M Coquet; J Maupetit
Journal:  Nouv Presse Med       Date:  1981-09-19

6.  Iatrogenic neurological diseases of the peripheral nervous system.

Authors:  N Baumann; J J Hauw
Journal:  Prog Clin Biol Res       Date:  1980

7.  Amiodaron neuropathy: further arguments for human drug-induced neurolipidosis.

Authors:  J F Lemaire; A Autret; K Biziere; J L Romet-Lemone; F Gray
Journal:  Eur Neurol       Date:  1982 Jan-Feb       Impact factor: 1.710

8.  High-performance liquid chromatographic measurement of amiodarone and its desethyl metabolite: methodology and preliminary observations.

Authors:  G C Storey; D W Holt; P Holt; P V Curry
Journal:  Ther Drug Monit       Date:  1982       Impact factor: 3.681

9.  Neuromyopathy during chronic amiodarone treatment. A case report.

Authors:  C Meier; B Kauer; U Müller; H P Ludin
Journal:  J Neurol       Date:  1979-01-05       Impact factor: 4.849

10.  [Amiodaron neuropathy: clinical and pathological study of a new drug induced lipidosis (author's transl)].

Authors:  P Dudognon; J J Hauw; C de Baecque; J P Derrida; R Escourolle; E J Nick
Journal:  Rev Neurol (Paris)       Date:  1979 Jul-Aug       Impact factor: 2.607
View more
  3 in total

1.  Unusual amiodarone toxicity in a child.

Authors:  Bahram Kakavand; Thomas G Di Sessa
Journal:  J Pediatr Pharmacol Ther       Date:  2008-04

2.  Antiarrhythmic drugs and polyneuropathy. The Collaborative Group for the Study of Polyneuropathy.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

3.  Amiodarone Alters Cholesterol Biosynthesis through Tissue-Dependent Inhibition of Emopamil Binding Protein and Dehydrocholesterol Reductase 24.

Authors:  Luke B Allen; Thiago C Genaro-Mattos; Allison Anderson; Ned A Porter; Károly Mirnics; Zeljka Korade
Journal:  ACS Chem Neurosci       Date:  2020-04-29       Impact factor: 4.418
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.